# Zhejiang Langhua Pharmaceutical Co. Ltd. – FDA Inspection, Mar 23, 2018

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-langhua-pharmaceutical-co-ltd/464625d5-0853-4c30-b35b-a2cf1075fc6a
Source feed: FDA_Inspections

> FDA inspection 1049002 of Zhejiang Langhua Pharmaceutical Co. Ltd., March 23, 2018. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049002
- Company Name: Zhejiang Langhua Pharmaceutical Co. Ltd.
- Inspection Date: 2018-03-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1250797 - 2024-08-30](https://www.keypedia.com/records/fda_inspections/zhejiang-langhua-pharmaceutical-co-ltd/b21ab25a-1b58-4d2a-b235-eee5dd933e10)
- [FDA Inspection 906650 - 2014-11-21](https://www.keypedia.com/records/fda_inspections/zhejiang-langhua-pharmaceutical-co-ltd/ffd85d4b-d8db-46e2-abfc-b8bd1f074dbb)
- FDA Inspection 774858 - 2012-03-01

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nadeem-i-chaudhry/7d867939-2dc6-4503-b9b9-6f26b16c347e)

Company: https://www.keypedia.com/companies/zhejiang-langhua-pharmaceutical-co-ltd/ee17277b-cc6d-4835-83b4-e864fa1b802c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c